Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-24-019373

Chief Financial Officer sold 248 shares at $4.98 ($1,235)

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-18 Sale : show line 1 in the form −248 $4.98 $1,235 154,330 D
Open-market sales · 248 sh · avg $4.98 · $1,235
Loading xslF345X05/form4.xml…